USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: FIRST LIGHT BIOSCIENCES, INC.
City: BEDFORD
State: MA
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $899,362.00 3
SBIR Phase II $10,199,851.00 3

Award List:

Rapid Ultra-Sensitive On-Site Biowarfare Agent Detection

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Donald Straus
Award Amount: $119,820.00
Abstract:
DESCRIPTION (provided by applicant): The bioterrorism attacks of 2001 highlighted the acute need for rapid, ultra-sensitive, cost-effective, and user-friendly tests to simultaneously screen for multiple types of biowarfare agents at the point of exposure. The goal of the proposed project is to… More

Rapid, accurate and user-friendly clinical surge-testing for biothreat agents

Award Year / Program / Phase: 2005 / SBIR / Phase II
Agency: HHS
Principal Investigator: Donald Straus
Award Amount: $4,300,457.00
Abstract:
DESCRIPTION (provided by applicant): Following a bioterrorist attack, hundreds of thousands of potential victims may require testing and treatment. The critical need to test large numbers of people for exposure to a biothreat agent may overwhelm the capacity of the clinical and public health… More

Ultrasensitive, rapid, cost-effective, user-friendly test for respiratory viruses

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $209,600.00
Abstract:
DESCRIPTION (provided by applicant): We propose to develop a novel testing platform for enabling rapid, ultrasensitive, accurate, user-friendly, and cost-effective point-of-care respiratory diagnostics for viral infections. Viral respiratory infections res ult in hundreds of thousands of deaths and… More

Rapid sensitive low cost test for resistant microbes causing hospital infections

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $569,942.00
Abstract:
DESCRIPTION (provided by applicant): We propose to develop a novel testing platform to enable rapid, ultrasensitive, accurate, user-friendly, and cost-effective screening for the antibiotic resistant bacteria that frequently cause serious hospital acquired infections. Every year, nearly 100,000… More

Rapid, accurate and user-friendly clinical surge-testing for biothreat agents

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Sadanand Gite
Award Amount: $2,992,554.00
Abstract:
DESCRIPTION (provided by applicant): Following a major bioterrorism attack or infectious disease outbreak, millions of potential victims may require rapid testing to ensure delivery of life-saving therapeutic treatment to those who need it. Because today t here is no diagnostic method capable of… More

Rapid sensitive low-cost test for resistant microbes causing hospital infections

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Sadanand Gite – 617-230-6440
Award Amount: $2,906,840.00
Abstract:
DESCRIPTION (provided by applicant): We propose to develop a novel automated platform to enable rapid, sensitive, user-friendly, and cost-effective screening for the antibiotic resistant bacteria that frequently cause serious healthcare associated infections. Every year, about 100,000 deaths result… More